Inflammation and diabetic nephropathy
Authors:
- 1 November 2006
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 6 (6) , 463-468
Abstract
Diabetic nephropathy has become the main cause of renal failure, but unfortunately the intimate mechanisms leading to the development and progression of renal injury are not yet fully known. Activated innate immunity and inflammation are relevant factors in the pathogenesis of diabetes. Moreover, different inflammatory molecules, including chemokines, adhesion molecules, and proinflammatory cytokines, may be critical factors in the development of microvascular diabetic complications, including nephropathy. This new pathogenic perspective leads to important therapeutic considerations, with new pathogenic pathways becoming important therapeutic targets that can be translated into clinical treatments for diabetic nephropathy.Keywords
This publication has 77 references indexed in Scilit:
- Spironolactone Prevents Diabetic Nephropathy through an Anti-Inflammatory Mechanism in Type 2 Diabetic RatsJournal of the American Society of Nephrology, 2006
- Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseasesKidney International, 2006
- Spironolactone prevents early renal injury in streptozotocin-induced diabetic ratsKidney International, 2004
- Pentoxifylline suppresses renal tumour necrosis factor- and ameliorates experimental crescentic glomerulonephritis in ratsNephrology Dialysis Transplantation, 2004
- Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetesLife Sciences, 2000
- Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritisKidney International, 1999
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.Journal of Experimental Medicine, 1990
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1989
- Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cellsFEBS Letters, 1988